Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects
The true prevalence of facioscapulohumeral muscular dystrophy (FSHD) is unknown due to difficulties with accurate clinical evaluation and the complexities of current genetic diagnostics. Interestingly, all forms of FSHD are linked to epigenetic changes in the chromosome 4q35 D4Z4 macrosatellite, sug...
Main Authors: | Taylor Gould, Takako I. Jones, Peter L. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/8/1469 |
Similar Items
-
Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele
by: Premi Haynes, et al.
Published: (2018-08-01) -
Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
by: Charis L. Himeda, et al.
Published: (2021-03-01) -
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
by: Emanuele Mocciaro, et al.
Published: (2021-11-01) -
Culture Conditions Affect Expression of DUX4 in FSHD Myoblasts
by: Sachchida Nand Pandey, et al.
Published: (2015-05-01) -
An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
by: Matthew V Cowley, et al.
Published: (2023-05-01)